Skip to main content
. Author manuscript; available in PMC: 2010 Dec 8.
Published in final edited form as: Nat Genet. 2009 May 10;41(6):677–687. doi: 10.1038/ng.384

Table 4.

Meta-analysis of CHARGE and Global BPgen of Top 10 Loci for Systolic and Diastolic Blood Pressure and Hypertension in CHARGE

CHARGE meta-analysis results Global BPgen meta-analysis results CHARGE + Global BPgen meta-analysis

SNP identifier Chr Position Nearest Gene Alleles (coded / other) Freq. of coded allele Beta SE p-value Beta SE p-value Beta SE p-value
Systolic blood pressure
rs12046278 1 10,722,164 CASZ1 T/C 0.64 -0.84 0.18 1.84E-06 -0.29 0.15 5.71E-02 -0.53 0.12 4.77E-06
rs7571613 2 190,513,907 PMS1 A/G 0.82 -0.96 0.19 7.28E-07 -0.23 0.16 1.59E-01 -0.54 0.13 1.90E-05
rs448378 3 170,583,593 MDS1 A/G 0.52 -0.71 0.15 1.28E-06 -0.36 0.13 4.76E-03 -0.51 0.10 1.18E-07
rs2736376 8 11,155,175 MTMR9 C/G 0.13 -1.08 0.23 1.90E-06 -0.06 0.19 7.36E-01 -0.48 0.15 9.15E-04
rs1910252 8 49,569,915 EFCAB1 T/C 0.18 -0.93 0.19 1.70E-06 -0.07 0.17 6.80E-01 -0.43 0.13 6.13E-04
rs11014166 10 18,748,804 CACNB2 A/T 0.66 0.74 0.16 2.11E-06 0.33 0.13 1.31E-02 0.50 0.10 7.03E-07
rs1004467 10 104,584,497 CYP17A1 A/G 0.90 1.20 0.25 1.99E-06 0.94 0.21 1.08E-05 1.05 0.16 1.28E-10
rs381815 11 16,858,844 PLEKHA7 T/C 0.26 0.84 0.17 5.76E-07 0.52 0.14 2.72E-04 0.65 0.11 1.89E-09
rs2681492 12 88,537,220 ATP2B1 T/C 0.80 1.26 0.19 3.01E-11 0.50 0.17 4.07E-03 0.85 0.13 3.76E-11
rs3184504 12 110,368,991 SH2B3 T/C 0.48 0.75 0.15 5.73E-07 0.45 0.13 6.36E-04 0.58 0.10 4.52E-09

Diastolic blood pressure
rs13423988 2 68,764,770 GPR73/ARHGAP25 T/C 0.17 0.59 0.12 1.09E-06 0.11 0.11 3.22E-01 0.33 0.08 5.00E-05
rs13401889 2 190,618,804 MSTN T/C 0.79 -0.54 0.11 9.58E-07 -0.10 0.11 3.55E-01 -0.31 0.08 4.82E-05
rs9815354 3 41,887,655 ULK4 A/G 0.17 0.60 0.12 7.88E-07 0.40 0.11 3.79E-04 0.49 0.08 2.54E-09
rs7016759 8 49,574,969 EFCAB1 T/C 0.83 0.57 0.12 1.87E-06 0.06 0.11 5.79E-01 0.30 0.08 2.29E-04
rs11014166 10 18,748,804 CACNB2 A/T 0.66 0.46 0.09 8.82E-07 0.28 0.09 1.46E-03 0.37 0.06 1.24E-08
rs11024074 11 16,873,795 PLEKHA7 T/C 0.72 -0.50 0.10 2.83E-07 -0.17 0.09 6.82E-02 -0.33 0.07 1.20E-06
rs2681472 12 88,533,090 ATP2B1 A/G 0.83 0.64 0.12 3.74E-08 0.36 0.12 2.43E-03 0.50 0.08 1.47E-09
rs3184504 12 110,368,991 SH2B3 T/C 0.48 0.50 0.09 1.68E-08 0.45 0.09 2.83E-07 0.48 0.06 2.58E-14
rs2384550 12 113,837,114 TBX3/TBX5 A/G 0.35 -0.48 0.09 1.32E-07 -0.23 0.09 1.06E-02 -0.35 0.06 3.75E-08
rs6495122 15 72,912,698 CSK/ULK3 A/C 0.42 0.45 0.09 8.10E-07 0.35 0.09 3.98E-05 0.40 0.06 1.84E-10

Hypertension
rs17806132 2 190,416,532 PMS1 A/G 0.16 0.14 0.03 1.14E-05 0.04 0.04 2.87E-01 0.10 0.02 4.70E-05
rs305489 3 11,986,163 SYN2 A/G 0.55 0.10 0.02 4.20E-06 0.01 0.03 7.75E-01 0.06 0.02 1.70E-04
rs7640747 3 37,571,809 ITGA9 C/G 0.62 -0.12 0.02 4.53E-07 -0.02 0.03 4.12E-01 -0.08 0.02 1.24E-05
rs11775334 8 10,109,030 MSRA A/G 0.32 0.10 0.02 1.03E-05 0.05 0.03 5.86E-02 0.08 0.02 4.05E-06
rs899364 8 11,366,954 FAM167A/BLK T/G 0.32 -0.10 0.02 6.95E-06 -0.04 0.03 1.32E-01 -0.08 0.02 1.01E-05
rs11014166 10 18,748,804 CACNB2 A/T 0.66 0.11 0.02 7.96E-07 0.07 0.03 1.06E-02 0.09 0.02 5.72E-08
rs2681472 12 88,533,090 ATP2B1 A/G 0.83 0.16 0.03 1.65E-08 0.13 0.04 2.15E-04 0.15 0.02 1.75E-11
rs278126 12 118,620,100 CIT T/G 0.28 0.11 0.02 8.34E-06 -0.01 0.03 6.72E-01 0.06 0.02 1.74E-03
rs11612893 12 129,290,572 FZD10/PIWIL1 T/G 0.10 -0.19 0.04 7.62E-06 -0.04 0.06 4.19E-01 -0.14 0.03 5.50E-05
rs16982520 20 57,192,115 ZNF831/ EDN3 A/G 0.88 -0.14 0.03 4.95E-06 -0.11 0.04 7.44E-03 -0.13 0.02 1.59E-07

Chr=chromosome;

SNPs in bold attained p <5×10-8 in meta-analysis of CHARGE and Global BPgen